Cargando…

Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy

BACKGROUND: Post‐radiotherapy locally recurrent prostate cancer (PCa) patients are candidates for focal salvage treatment. Multiparametric MRI (mp‐MRI) is attractive for tumor localization. However, radiotherapy‐induced tissue changes complicate image interpretation. To develop focal salvage strateg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dinis Fernandes, Catarina, van Houdt, Petra J., Heijmink, Stijn W.T.P.J., Walraven, Iris, Keesman, Rick, Smolic, Milena, Ghobadi, Ghazaleh, van der Poel, Henk G., Schoots, Ivo G., Pos, Floris J., van der Heide, Uulke A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618021/ https://www.ncbi.nlm.nih.gov/pubmed/30585368 http://dx.doi.org/10.1002/jmri.26581

Ejemplares similares

Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
por: Van der Roest, Rosanne CV., et al.
Publicado: (2016)

Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
por: Klawer, Edzo M.E., et al.
Publicado: (2018)

Improved repeatability of dynamic contrast‐enhanced MRI using the complex MRI signal to derive arterial input functions: a test‐retest study in prostate cancer patients
por: Klawer, Edzo M.E., et al.
Publicado: (2019)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer
por: Dinis Fernandes, Catarina, et al.
Publicado: (2023)

Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
por: Kooreman, Ernst S., et al.
Publicado: (2021)

Longitudinal Correlations Between Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced (DCE) MRI During Radiotherapy in Prostate Cancer Patients
por: Kooreman, Ernst S., et al.
Publicado: (2022)

Clinical workflow for treating patients with a metallic hip prosthesis using magnetic resonance imaging-guided radiotherapy
por: Keesman, Rick, et al.
Publicado: (2020)

Prostate MRI for Improving Personalized Risk Prediction of Incontinence and Surgical Planning: The Role of Membranous Urethral Length Measurements and the Use of 3D Models
por: Boellaard, Thierry N., et al.
Publicado: (2023)

Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway()
por: Dickinson, Louise, et al.
Publicado: (2013)

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
por: Donswijk, Maarten L., et al.
Publicado: (2020)

Imaging for radiation treatment planning and monitoring in prostate Cancer: Precision, personalization, individualization of therapy
por: Grosu, Anca-Ligia, et al.
Publicado: (2019)

Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy
por: van Houdt, Petra J., et al.
Publicado: (2021)

The primacy of multiparametric MRI in men with suspected prostate cancer
por: Richenberg, Jonathan, et al.
Publicado: (2019)

Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial
por: Lips, Irene M, et al.
Publicado: (2011)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patients
por: Nowee, M.E., et al.
Publicado: (2021)

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options
por: Zuur, Lotte G., et al.
Publicado: (2023)

Abandon the Label of Clinically Insignificant Prostate Cancer
por: Mertens, Laura S., et al.
Publicado: (2022)

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis
por: Hagens, Marinus J., et al.
Publicado: (2022)

Specialist versus Primary Care Prostate Cancer Follow-Up: A Process Evaluation of a Randomized Controlled Trial
por: Wollersheim, Barbara M., et al.
Publicado: (2022)

Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure
por: Feldman, E., et al.
Publicado: (2023)

Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging
por: Meijer, Dennie, et al.
Publicado: (2021)

Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator
por: den Hartogh, Mariska D., et al.
Publicado: (2019)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
por: Deijen, Charlotte L., et al.
Publicado: (2021)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy
por: de Barros, Hilda A., et al.
Publicado: (2023)

MRI basics for radiation oncologists
por: van der Heide, Uulke A., et al.
Publicado: (2019)

Repeatability of Multiparametric Prostate MRI Radiomics Features
por: Schwier, Michael, et al.
Publicado: (2019)

Prostatic Leiomyoma – Multiparametric Prostate MRI Features
por: Vergauwen, Ortwin, et al.
Publicado: (2018)

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
por: Willis, Sarah R, et al.
Publicado: (2014)

Multiparametric MRI in Prostate Cancer
por: Esen, Tarık, et al.
Publicado: (2014)

Multiparametric ultrasound of prostate: role in prostate cancer diagnosis
por: Kaneko, Masatomo, et al.
Publicado: (2022)

An Magnetic Resonance Imaging–directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: “Less Is More”
por: Hagens, Marinus J., et al.
Publicado: (2022)

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients
por: Lips, Irene M, et al.
Publicado: (2008)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics
por: Siefert, Joseph C., et al.
Publicado: (2021)

Multimodal imaging for radiation therapy planning in patients with primary prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_43u6crd0pk7e8id5fdfgu6k1r9